A letter was sent to a number of hospitals and systems, including Washington University in St. Louis, Southampton Healthcare in St. Louis and Children’s Mercy in Kansas City, according to an Aug. 30 news release.
The letter informed providers they “must immediately cease and desist performing gender transition surgeries on minors” and can no longer administer puberty blockers or cross-sex hormones to new patients, although they are allowed to continue providing those treatments to patients already receiving them before Aug. 28.
Under the SAFE Act, providers who knowingly violate the law can have their license revoked.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
